| 137. | ||
|
Maertens J, Raad I, Sable CA, et al. Multicenter, noncomparative study to evaluate safety and
efficacy of caspofungin in adults with invasive aspergillosis refractory or intolerant to amphotericin B, lipid amphotericin B, or azoles.Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy [abstract 1103]. Toronto, Canada, 2000.
|
||
| Close this window | ||